WeVote

Bill

Bill

S 9523

Relates to coverage for treatments to slow the progression of Alzheimer's disease and related dementias

2025 Regular Session Introduced by Joe Addabbo and 5 co-sponsors

New York insurers must cover medically necessary diagnostic tests and FDA-approved treatments to slow Alzheimer's progression, with no step therapy.

REFERRED TO INSURANCE
0

WeVote — Public opinion

No community votes yet. Be the first to weigh in from the Vote tab.

Bill text & amendments

No documents yet

The official bill text and any amendments will be posted here once available.